Cochrane Abstracts
Dopamine versus dobutamine for hypotensive preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Versus Dobutamine for Hypotensive Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439060/all/Dopamine_versus_dobutamine_for_hypotensive_preterm_infants.
Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439060/all/Dopamine_versus_dobutamine_for_hypotensive_preterm_infants. Accessed February 8, 2026.
Dopamine versus dobutamine for hypotensive preterm infants. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439060/all/Dopamine_versus_dobutamine_for_hypotensive_preterm_infants
Dopamine Versus Dobutamine for Hypotensive Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439060/all/Dopamine_versus_dobutamine_for_hypotensive_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine versus dobutamine for hypotensive preterm infants
ID - 439060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439060/all/Dopamine_versus_dobutamine_for_hypotensive_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
